Skip to content
About Us
Our Founders & Our Story
Leadership
Advisory Board
Our Team
Our Values
Investors
MicroOrganoSphere
TM
(MOS)
Technology
Precision
Oncology
Colorectal Cancer
Breast Cancer
Immuno-oncology
Drug
Development
Collaborators
News &
Publications
Careers
Contact Us
Menu
Establishing functional models of peritoneal carcinomatosis using MicroOrganoSphere (MOS) technology
Post navigation
Previous Post
MicroOrganoSpheres as a Clinically Applicable Precision Oncology Platform for the Discovery of Novel Therapies in Colorectal Cancer
Next Post
A functional immuno-oncology (IO) assay to assess patient response to immunotherapeutics in metastatic disease
vera
View posts by vera
Scroll to top
Copy
Email
Share on Mastodon
Enter your Mastodon instance URL (optional)
Share
